<DOC>
	<DOCNO>NCT00690209</DOCNO>
	<brief_summary>Surgical revascularization proven efficacy term morbidity mortality patient multivessel coronary disease poor leave ventricular function . Nevertheless , leave ventricle severely dilate , improvement global contractility reduction volume frequently absent CABG even substantial amount myocardial viability present . A value &gt; 140 ml end systolic volume propose cut absence recovery revascularization . Recently , reduction cardiac volume improvement regional global contractility demonstrate patient advanced ischemic heart disease , severe dilation leave ventricle poor candidate revascularization injection stem cell territories residual viability .</brief_summary>
	<brief_title>By Pass Surgery With Stem Cell Therapy Chronic Ischemic Cardiopathy</brief_title>
	<detailed_description>The screening patient perform contrast coronar ventriculography realize diagnostic prognostic purpose . Subsequently patient evaluate cardiac ce-MR PET image verification inclusion criterion . Patients allocate single blind manner one two therapeutic arm : surgical revascularization alone surgical revascularization associate autologous bone marrow derive stem cell injection viable territory . During follow evolution leave ventricular volume contractility analyze ce-MR PET image 1 year . Additionally patient ' functional status assess metabolic stress test quality life questionnaire 6 month , 1 year 2 year .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Chronic ischemic heart disease Left ventricular dilation ( end systolic volume &gt; 140 ml ) Poor global contractile function ( ejection fraction &lt; 40 % ) Substantial amount residual viability ( &gt; 30 % left ventricle )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Chronic ischemic cardiomyopathy residual viability</keyword>
	<keyword>surgical coronary revascularization</keyword>
	<keyword>stem cell therapy</keyword>
	<keyword>Chronic ischemic heart disease</keyword>
	<keyword>severe impairment global contractility leave ventricular dilation</keyword>
	<keyword>residual viability</keyword>
</DOC>